SlideShare una empresa de Scribd logo
1 de 155
The impact of SSC 2012 on the panning
and evaluation of my hospital's
performance
Critical Care Department - Hospital Vall d'Hebron
Barcelona, June, 10, 2013
Rui Moreno
UCINC, Hospital de São José
Centro Hospitalar de Lisboa Central, E.P.E.
DECLARATION OF POTENTIAL (REAL)
CONFLICT OF INTEREST
DECLARATION OF POTENTIAL CONFLICT OF INTEREST
• I am not an Anaesthesiologist
• I am not and Internist
• I am not a surgeon
• I am not a GP
DECLARATION OF POTENTIAL CONFLICT OF INTEREST
• I am not an Anaesthesiologist
• I am not and Internist
• I am not a surgeon
• I am not a GP
I AM AN INTENSIVIST!
THE PATIENT WITH SEPSIS NEED
TEAMS, NOT TRIBES!
Sepsis = Decomposition,
decay
Septic = Rotten
Σήψις
DEFINITIONS
Bone et al. Chest. 1992;101:1644;
Wheeler and Bernard. N Engl J Med.
1999;340:207.
SepsisSIRSInfection/
Trauma
Severe Sepsis
Sepsis with ≥1 sign of organ
failure
 Cardiovascular (refractory
hypotension)
 Renal
 Respiratory
 Hepatic
 Hematologic
 CNS
 Unexplained metabolic
acidosis
Shock
800
1,000
1,200
1,400
1,600
1,800
2001 2025 2050
Year
300
400
500
600
SepsisCases(x103)
TotalUSPopulation(million)
Angus DC, et al. JAMA 2000;284:2762-70.
Angus DC, et al. Crit Care Med 2001;29:1303-10.
SEVERE SEPSIS IS INCREASING IN INCIDENCE
Severe Sepsis Cases
US Population
EPIDEMIOLOGY OF SEPSIS IN THE CRITICALLY
ILL PATIENT
0%
10%
20%
30%
40%
50%
60%
70%
80%
0-1 2-3 4-6 7-10 11-15 16-21
Days in ICU before the study day
Infectionrate
N = 6010 1608 1857 1248 1176 742
(EPIC II, 2008)
INFECTION AND OUTCOME
0,0
5,0
10,0
15,0
20,0
25,0
30,0
35,0
40,0
45,0
Mortality,%
ICU mortality 13,9 32,2
Hospital mortality 18,7 41,8
No infection Infection
(Moreno et al. 2005 - data from the SAPS 3 study)
0%
25%
50%
75%
100%
%ofpatients
0 2 4 6 8 10 12 14 16 18 20 22 24
SOFA score
Survivors Non-survivors
(R. Moreno, 1997)
EPIDEMIOLOGY OF SEPSIS IN THE CRITICALLY
ILL PATIENT
1 OSF
2 OSF
3 OSF
0
20
40
60
80
100
1 2 3 4 5 6 7
ICUmortality(%)
Number of days in MOF
ORGAN FAILURE AND MORTALITY IN PATIENTS WITH SEPSIS
AND ORGAN FAILURE
(data from Moreno et al.)
DECLARATION OF BARCELA
2002
Surviving Sepsis Campaign: Timeline
Barcelona
Declaration
SSC Guidelines
2010
???
Guidelines
And bundles
Revision
2005
NEJM editorial
2004
2002
Guidelines
Revision
Phase III starts:
IHI partnership
2008 2012
Results
published
15,000 pts
20% RRR
2006
2012--
Surviving Sepsis Campaign
Guidelines for Management of Severe
Sepsis/Septic Shock
2004
Surviving Sepsis Campaign
Guidelines for Management of Severe
Sepsis/Septic Shock
2008
Surviving Sepsis Campaign
Guidelines for Management of Severe
Sepsis/Septic Shock
2012
Surviving Sepsis — Practice Guidelines, Marketing Campaigns, and Eli Lilly
Peter Q. Eichacker, M.D., Charles Natanson, M.D., and Robert L. Danner, M.D
New Policy to deal with Potential Conflicts of Interest
GRADE PRO: Guideline development process
• Prioritize problems (and define specific question(s)
• Perform systematic review
• Summarize the evidence in evidence profiles (summary of
findings tables)
• Judge which outcomes are critical
• Judge overall quality of evidence
• Judge balance of benefits and downsides
• Generate recommendation
• Judge strength of recommendation
42
43
4.5 potentials for a mishap per operation
NURSING WORK
Gets IV bags,
Checks
orders in binder
13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00
Hangs IV
IV push Oral meds,
topical
cream
Checks
updates
in computer
Hangs IV
Planning for
new shift
Checks
orders in
binderHangs IV
Hangs IV
Hangs IV
Oral meds
IV push
Oral meds
Insulin
Hangs IV
Pain med
Checks
updates
in computer
Topical
cream
Other RN
needs binder
Nursing home
assessment
Narcotic keys
Staffing
IV pump alarm
Fingerstick
machine
calibration
Hand off
assessment
IV pump alarm
Narcotic meds
too many to
put in cart
Narcotic keys
Other RN
leaves floor
Signature for
narcotics
Move patient
to new bed
Water for
patient
New nursing
assistant
arrives
MD asks to tape
down IV
LPN she is
covering
Children on
floor
Patient risk of
falling
Other RN
returns
Hang IV
for her
Pain med
request
BP machine
problems
Dinner
Patient
moved up in
bed
Water for
patient
Fingerstick
machine
IV pump alarm
Beds
Weigh
patient
Staffing
Other RN
dinner
Hang IV
IV pump alarm
Cart
Wife of patient
Emily S. Patterson PhD
Surviving Sepsis Campaign
Guidelines for Management of Severe
Sepsis/Septic Shock
Version 2012
Direct medical costs
van Beeck et al. J Trauma 1997;42:1116
TRAFFIC INJURIES
0 10 20 30 40 50 60 70 80 90
0
10
20
Age in years
MillionsofUS$
Male
Female
van Beeck et al. J Trauma 1997;42:1116
OCCUPATIONAL INJURIES
0 10 20 30 40 50 60 70 80 90
0
1
2
3
4
5
Male
Female
Age in years
MillionsofUS$
DOMESTIC INJURIES
0 10 20 30 40 50 60 70 80 90
0
10
20
30
40
50
60
70
80
90
100
Age in years
MillionsofUS$
van Beeck et al. J Trauma 1997;42:1116
Male
Female
2000
2200
2400
2600
2800
3000
3200
3400
3600
1990 1991 1992 1993 1994 1995
Totalexpenditureinacutecare-MillionEuro
Years
Denmark
TOTAL EXPENDITURE IN HEALTH CARE
Direct medical costs
IF WE WANT TO AVOID A DISASTER
OUR FOCUS SHOULD BE ON
THE EVALUATION AND OPTIMIZATION
OF THE SERVICES WE PROVIDE
HOW (UN)RELIABLE IS MEDICINE?
• 10-1 means that 1 to 9 times out of 10 the intended actions fail to
produce the desired results or are defective. An example is if I
have a 80% compliance with giving appropriate DVT prophylaxis
there are 2 defects in our process in every 10 patients
• 10-2 means that 1 to 9 times out of 100 the intended action or
results fail or are defective. An example is if I have 96%
compliance with giving appropriate DVT prophylaxis there will be
4 defects in our process in every 100 patients
Average
Percent
High
Income
Zip
Codes
Low
Income
Zip
Codes
Expected
in One
Year
Diabetic Eye
Exams
47,9 53,2 44,9 100,0
Hgb A1c
Monitoring
55,9 59,5 50,9 100,0
Mammography
Screening
46,7 50,8 39,8 100,0
Colon Cancer
Screening
9.0 (45%) 10,3 8,0 20,0
Influenza Vaccine 46,5 50,8 41,5 100,0
Pneunococcal
Vaccine
8 (80%) 8,7 7,3 10,0
Pham HH. Delivery of
Preventive Services. JAMA
2005; 294:473-481
WHAT ARE OUR EXPECTATIONS OF RELIABILITY IN OTHER
INDUSTRIES?
1. How many of you would put up with your automobile not
starting two out of ten starts?
2. How many of you would fly commercially, if airplanes
crashed or abandoned the trip one out of every ten flights?
3. How many of you would frequent a restaurant that served
contaminated food three times out of every ten meals?
HEALTH CARE RELIABILITIES
(Un)Reliability Outcome/Process
10-1
Beta blockers and ASA in Acute MI
HgA1c tested at least 3 times every 2 yrs Mammograms,
Immunization
Lower Vt in ALI Patients.
10-2
Serious adverse events in hospital
Deaths in high risk surgery
10-3
Neonatal mortality
General surgery deaths
10-4 Deaths in routine anesthesia
10-5 Blood Banking
10-6 ?
10.3 10.5 10.3 9.6 8
7.7 6.9
2 2 2 2
12
21
31
0
5
10
15
20
25
30
35
1996 1997 1998 1999 2000 2001 2002
Median Vt ml/kg % of ARDS Patients Recieving 6 ml/kg Vt
ARDS Network Paper Published NEJM May 2000
Death deceased from 40% to 31% p= 0.007
(Am J. Respir & CCM 2004; 169 supp:A256)
10.3 10.5 10.3 9.6 8
7.7 6.9
2 2 2 2
12
21
31
0
5
10
15
20
25
30
35
1996 1997 1998 1999 2000 2001 2002
Median Vt ml/kg % of ARDS Patients Recieving 6 ml/kg Vt
ARDS Network Paper Published NEJM May 2000
Death deceased from 40% to 31% p= 0.007
Two Years after publishing the evidence,
‘7’ of 10 patients are NOT receiving best
care
(Am J. Respir & CCM 2004; 169 supp:A256)
TIDAL VOLUME IN THE ICU’S
0
2
4
6
8
10
12
Luhr 1999 Esteban 2000 Esteban 2002 Esteban 2002 ALIVE 2004 SAPS3
mL/kg
(João Gouveia et al. Data from the SAPS 3 study)
PEEP IN THE ICU’S
0
2
4
6
8
10
12
14
Luhr 1999 Esteban
2000
Esteban
2002
Esteban
2002
ALIVE 2004 SAPS3
cmH2O
(João Gouveia et al. Data from the SAPS 3 study)
We demand the right to make bad
choices.
Bad choices yield bad results
4.5 potentials for a mishap per operation
NURSING WORK
Gets IV bags,
Checks
orders in binder
13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00
Hangs IV
IV push Oral meds,
topical
cream
Checks
updates
in computer
Hangs IV
Planning for
new shift
Checks
orders in
binderHangs IV
Hangs IV
Hangs IV
Oral meds
IV push
Oral meds
Insulin
Hangs IV
Pain med
Checks
updates
in computer
Topical
cream
Other RN
needs binder
Nursing home
assessment
Narcotic keys
Staffing
IV pump alarm
Fingerstick
machine
calibration
Hand off
assessment
IV pump alarm
Narcotic meds
too many to
put in cart
Narcotic keys
Other RN
leaves floor
Signature for
narcotics
Move patient
to new bed
Water for
patient
New nursing
assistant
arrives
MD asks to tape
down IV
LPN she is
covering
Children on
floor
Patient risk of
falling
Other RN
returns
Hang IV
for her
Pain med
request
BP machine
problems
Dinner
Patient
moved up in
bed
Water for
patient
Fingerstick
machine
IV pump alarm
Beds
Weigh
patient
Staffing
Other RN
dinner
Hang IV
IV pump alarm
Cart
Wife of patient
Emily S. Patterson PhD
Revised SSC Bundles
• Based on 2012 SSC guideline Revision
• Utilizing analysis of 28,000 pt in the SSC
database
• New software to be developed
• No industry funding utilized in revising guidelines or
bundles
Revised SSC Bundles
• Management bundle dropped
• IPP: High compliance at outset of study
• No significant change in compliance
• Glucose:
• Clouded by controversy
• Steroids:
• OR > 1.0 in SSC analysis
• rhAPC:
• Significant OR for survival but after the results of
PROWESS-SHOCK was withdraw from all markets
Sepsis Resuscitation Bundle
(To be started immediately and completed within 3 hours)
• Serum lactate measured in 3 hours.
• Blood cultures obtained prior to antibiotic administration.
• Minimize time to administration of broad-spectrum
antibiotics with a maximum of 3 hours.
• In the event of hypotension and/or lactate >
3mmol/L, deliver a minimum bolus of 30 ml/kg of
crystalloid (or colloid equivalent) within 1 hour.
Septic Shock Bundle
(To be started immediately and completed within 6 hours)
• Apply vasopressors for hypotension not responding to initial
fluid resuscitation to maintain mean arterial pressure (MAP) >
65 mm Hg.
• In the event of persistent arterial hypotension despite volume
resuscitation (septic shock) and/or initial lactate > 4 mmol/L
(36 mg/dl):
• Insert central line
• Achieve central venous pressure (CVP) of > 8 mm Hg.
• Achieve central venous oxygen saturation (ScvO2) of > 70%.
Role of Collaboration
ICUED
SOAP AND SEPSIS-ANALYZING WHAT COMES OUT IN
THE WASH
• From the data they obtained, Dr. Vincent and colleagues
make a number of observations:
• First, sepsis occurs frequently, being reported in almost 40% of
patients in the ICU
• Second, the frequency of sepsis varies markedly between
countries, and countries with higher frequencies of sepsis have
higher mortality rates among all patients admitted to the ICU.
• Finally, they report that the presence of a positive cumulative
fluid balance over the first 72 hrs from the onset of sepsis is,
among other variables, independently associated with higher
ICU mortality.
Warren Lee & Niall Ferguson. Critical Care Medicine2006; 34:552-554)
SOAP AND SEPSIS-ANALYZING WHAT COMES OUT IN
THE WASH
Warren Lee & Niall Ferguson. Critical Care Medicine2006; 34:552-554 )
SOAP AND SEPSIS-ANALYZING WHAT COMES OUT IN
THE WASH
• Data demonstrate that the mortality rate from organ failure
was the same for patients with severe sepsis as it was for
those without sepsis, suggesting that organ dysfunction,
rather than infection per se, is the key.
• What could account for these findings?
• ...difference in case-mix and ICU admission threshold
• ...the higher mortality rate in the ICUs with higher sepsis
prevalence might be a marker of overtaxed resources in
the ICU or during pre-ICU care
• ... it is tempting to speculate that baseline differences in
antibiotic use between ICUs may have contributed both to
the differences in the reported frequency of sepsis and to
the mortality rates observed.
Warren Lee & Niall Ferguson. Critical Care Medicine2006; 34:552-554 )
(Crit Care Med 2006; 34:211–218)
FINDING OUT WHAT WE DO IN THE ICU
Mitchell M. Levy, MD, FCCM
• This task force represents a change in focus, not only for
SCCM in particular but for the field of critical care in general.
• ...for a long time, SCCM, along with other critical care
societies, focused on the model of critical care delivery.
• Regardless of the model of critical care delivery, the most
important aspect of critical care is the quality of care patients
receive in a given ICU.
• For many years, the assessment of this quality was based
on measuring and reporting outcomes of care.
• Now, finally, there is a growing understanding that paying
attention to the details or process of care is the truly
essential aspect of quality measurement in the ICU.
(Crit Care Med 2006; 34:227–228)
FINDING OUT WHAT WE DO IN THE ICU
Mitchell M. Levy, MD, FCCM
• Curtis et al., at the direction of SCCM, have provided
clinicians in critical care units with a blue-print or mirror for
self-examination. The next step is for critical care clinicians
to look into that mirror and decide whether or not we like
what we see.
(Crit Care Med 2006; 34:227–228)
NEGOVSKY IBSEN SAFAR
WE HAVE STRONG SCIENTIFIC
FOUNDATIONS TO OUR SPECIALITY
FROM REANIMATION TO INTENSIVE CARE
MEDICINE
REANIMATION INTENSIVE CARE
INTENSIVE CARE MEDICINE
20 years ago Dr Bill Knaus acknowledged:
• It ’ s the human resources of the ICU
TEAM, their organization and
distribution, and how we apply technology
consistently, NOT the genius of
individuals or the treatment “ magic
bullet ” that leads to EFFICIENT and
EFFECTIVE ICU.
Knaus et al Annals Int Med 1986: 104.410
DISEASES THAT MADE THE ICU
Polio: Mortality 60% to 20% ??? (but just in
2 or 3 countries)
Tetanus: Mortality approaches Zero
Guillian-Barré syndrome: Mortality approaches Zero
Acute organophosphate poisoning: almost disapeared
Most of the mortality relates to co-morbidity and
complications of ICU treatment.
DEVELOPMENT AS A CHALENGE
• Education and training of new professionals.
• Training in Intensive care of other professionals.
• Better much between resources and workload.
• The flux of patients within the hospital: admission and
discharge policies, readmissions.
• Patient safety: prevention of adverse events.
• Organisative aspects: leadership, communication, team-
work.
Current and projected workforce requirements for
care of the critically ill.
Angus D et al. JAMA 2000 : 284; 2762-70
RETIRE FROM ICU CARE AT 77 YEARS:
(Angus et. Al, JAMA 2002)
0
50
100
150
200
250
300
350
400
2001 2006 2011 2016 2021 2026 2031
Year
At 2006 rates
Modelling trend
ICNARCIntensiveCareNationalAudit&ResearchCentre
160% increase in demand
over 10 years.
Projected ICU Bed Day Requirements
Rowan K et al
INTENSIVE CARE IS NOT ABOUT
MACHINES
IT IS ABOUT PEOPLE
IT IS ABOUT ORGANIZATION
12
12
NUMBER OF INTENSIVE CARE BEDS PER
100.000 INHABITANTS
Portugal
USA
França
UK
Canadá
Bélgica
Alemanha
HolandaEspanha
0
5
10
15
20
25
30
0 2 4 6 8 10
13
nºdecamasdeMedicinaIntensiva
por100.000habitantes
Países
(Data from Wunsch et all, 2008)
NUMBER OF INTENSIVE CARE BEDS PER
100.000 INHABITANTS
Portugal
USA
França
UK
Canadá
Suécia
Holanda
Espanha
Croácia
Bélgica
Alemanha
0
5
10
15
20
25
0 2 4 6 8 10 12 14
Trinidá e Tobago
13 Países
nºdecamasdeMedicinaIntensiva
por100.000habitantes
(Data from Adhikari et al., 2010)
13
• ≈2 millions
Total n° Acute Care Beds
• ≈ 60.000
Total N° IC Beds
• ≈3%
IC Beds/AC Beds %
Acute and intensive care beds in Europe…….
(Andrew Rhodes &
Rui Moreno, 2012, ICM)
Acute care beds
Acute care hospital beds
/ 100,000 population.
Total number of ICU and
IMCU care beds
Total Adult ICU and
IMCU beds / 100,000
population
Adult ICU beds as % of all
acute care beds
%>65
Andorra 188 224 6 7.1 3.2 13
Austria 48446 635 1833 21.8 3.4 18.2
Belgium 50156 456 1900 17.3 3.8 18
Bulgaria 57460 766 2154 28.7 3.7 18.2
Croatia 15629 353 650 14.7 4.2 16.9
Cyprus 2813 350 92 11.4 3.3 10.4
Czech Republic 91068 865 1227 11.6 1.3 16.3
Denmark 17124 308 372 6.7 2.2 17.1
Estonia 5096 380 262 19.5 5.1 17.7
Finland 12442 231 329 6.1 2.6 17.8
France 232821 358 10540 16.2 4.5 16.8
Germany 469791 575 23,890 29.2 5.1 20.6
Greece 44411 392 680 6 1.5 19.6
Hungary 41574 416 1374 13.8 3.3 16.9
Iceland 1169 367 29 9.1 2.5 12.7
Ireland 12202 272 289 6.5 2.4 11.6
Italy 201932 333 7,550 12.5 3.7 20.3
Latvia 11833 531 217 9.7 1.8 16.9
Lithuania 17061 526 502 15.5 2.9 16.5
Luxemberg 2511 491 127 24.8 5.1 14.9
Netherlands 56085 337 1065 6.4 1.9 15.6
Norway 13639 277 395 8 2.9 16
Poland 156662 410 2635 6.9 1.7 13.7
Portugal 31722 298 451 4.2 1.4 18
Romania 108611 507 4574 21.4 4.2 14.8
Slovakia 32560 599 500 9.2 1.5 12.8
Slovenia 7656 373 131 6.4 1.7 16.8
Spain 124194 269 4479 9.7 3.6 17.1
Sweden 26131 278 550 5.8 2.1 19.7
Switzerland 28096 357 866 11 3.1 17
United Kingdom 147809 237 4114 6.6 2.8 16.5
Total size of Population
Gross Domestic Product (GDP)
($millions)
Gross Domestic Product (GDP) per
inhabitant ($)
Total expenditure on health as a %
of GDP
Andorra 84082 2893 34,407 7.7
Austria 8404252 377,382 44,904 8.6
Belgium 11007020 467,779 42,498 8.2
Bulgaria 7504868 47,702 6,356 4.4
Croatia 4425747 60,834 13,745 7.8
Cyprus 804435 23,174 28,808 6.0
Czech Republic 10532770 192,030 18,232 6.9
Denmark 5560628 309,866 55,725 9.8
Estonia 1340194 19,253 14,366 5.3
Finland 5375276 239,177 44,496 6.8
France 65075310 2,562,742 39,381 9.2
Germany 81748892 3,286,451 40,202 8.9
Greece 11329618 305,415 26,957 5.8
Hungary 9986000 130,421 13,060 5.2
Iceland 318452 12,594 39,548 7.9
Ireland 4480176 206,985 46,200 7.2
Italy 60626508 2,055,114 33,898 7.4
Latvia 2229641 24,013 10,770 8.1
Lithuania 3244601 36,370 11,209 7.8
Luxemberg 511840 54,950 107,358 4.1
Netherlands 16654979 780,668 46,873 5.5
Norway 4920305 412,990 83,936 8.1
Poland 38200037 469,401 12,288 5.3
Portugal 10636979 229,154 21,543 5.7
Romania 21413815 161,629 7,548 5.4
Slovakia 5435273 87,450 16,089 6.0
Slovenia 2050189 47,733 23,282 6.8
Spain 46152926 1,409,946 30,549 7.0
Sweden 9415570 458,725 48,720 8.2
Switzerland 7866500 527920 67,110 6.8
United Kingdom 62435709 2,250,209 36,040 8.2
(Andrew Rhodes & Rui Moreno, 2012, ICM)
(Andrew Rhodes & Rui Moreno, 2012, ICM)
(Andrew Rhodes & Rui Moreno, 2012, ICM
(Andrew Rhodes & Rui Moreno, 2012, ICM)
(Andrew Rhodes & Rui Moreno, 2012, ICM
WE HAVE ARRIVED
DEVELOPMENT
AS AN
OPPORTUNITY
• Intensivist model
(closed) reduced
mortality. (OR: 0.71
95%CI 0.62-0.82)
• Intensivist model
(closed) reduced
length of stay
Pronovost et al. JAMA; 2002-2151
Physician staffing patterns and clinical
outcomes in critically ill patients.
Most Positive Factors Most Negative factors
Intellectual stimulation Lack of leisure time
Treating acutely ill patients Stress among faculty
Application of complex
physiology
Treating chronically ill patients
Procedure orientated Inconsistent with my personality
Dealing with end-of-life issues Dealing with complex ethical
issues.
Attitudes and Perceptions of Internal Medicine Residents
Regarding Pulmonary and Critical Care Subspecialty Training.
Lorin S et al. Chest 2005 : 127; 630-6.
“Beauty comes first. Victory is
secondary. What matters is joy.”
Sócrates Brasileiro
Sampaio de Souza Vieira de
Oliveira
14
STRESSED INTENSIVISTS ?
“The physician must be able to tell the antecedents, know the
present, and foretell the future- must mediate these things, and have
two special objects in view with regard to disease, namely, to do
good or to do no harm.
The art consists in three things- the disease, the patient, and the
physician. The physician is the servant of the art, and the patient
must combat the disease along with the physician.”
Hippocrates, in Epidemics, Book 1, section 11
Gràcies

Más contenido relacionado

Destacado

IEEE-MSIT X-quizite 2011. Finals - round 2
IEEE-MSIT X-quizite 2011. Finals - round 2IEEE-MSIT X-quizite 2011. Finals - round 2
IEEE-MSIT X-quizite 2011. Finals - round 2Ashutosh Varma
 
Homelessness in Billings 2012: Research and Trends
Homelessness in Billings 2012:  Research and TrendsHomelessness in Billings 2012:  Research and Trends
Homelessness in Billings 2012: Research and TrendsWelcomeHomeBillings
 
Cytomegalovirus (CMV) in Intensive Care Unit (ICU) patients (David Navarro, PhD)
Cytomegalovirus (CMV) in Intensive Care Unit (ICU) patients (David Navarro, PhD)Cytomegalovirus (CMV) in Intensive Care Unit (ICU) patients (David Navarro, PhD)
Cytomegalovirus (CMV) in Intensive Care Unit (ICU) patients (David Navarro, PhD)Vall d'Hebron Institute of Research (VHIR)
 
Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...Vall d'Hebron Institute of Research (VHIR)
 
Identification of pathological mutations from the single-gene case to exome p...
Identification of pathological mutations from the single-gene case to exome p...Identification of pathological mutations from the single-gene case to exome p...
Identification of pathological mutations from the single-gene case to exome p...Vall d'Hebron Institute of Research (VHIR)
 
Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...Vall d'Hebron Institute of Research (VHIR)
 
Lessonplan 100512115922-phpapp02 (2)
Lessonplan 100512115922-phpapp02 (2)Lessonplan 100512115922-phpapp02 (2)
Lessonplan 100512115922-phpapp02 (2)Roel Cortez
 
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp..."Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp...Vall d'Hebron Institute of Research (VHIR)
 
kyoto protocol & its impact on india
kyoto protocol & its impact on indiakyoto protocol & its impact on india
kyoto protocol & its impact on indiaHarshal Gala
 

Destacado (18)

IEEE-MSIT X-quizite 2011. Finals - round 2
IEEE-MSIT X-quizite 2011. Finals - round 2IEEE-MSIT X-quizite 2011. Finals - round 2
IEEE-MSIT X-quizite 2011. Finals - round 2
 
Repaso sexto (1)
Repaso sexto (1)Repaso sexto (1)
Repaso sexto (1)
 
Segundo avance
Segundo avanceSegundo avance
Segundo avance
 
Youth Count! 2013
Youth Count! 2013Youth Count! 2013
Youth Count! 2013
 
Homelessness in Billings 2012: Research and Trends
Homelessness in Billings 2012:  Research and TrendsHomelessness in Billings 2012:  Research and Trends
Homelessness in Billings 2012: Research and Trends
 
Cytomegalovirus (CMV) in Intensive Care Unit (ICU) patients (David Navarro, PhD)
Cytomegalovirus (CMV) in Intensive Care Unit (ICU) patients (David Navarro, PhD)Cytomegalovirus (CMV) in Intensive Care Unit (ICU) patients (David Navarro, PhD)
Cytomegalovirus (CMV) in Intensive Care Unit (ICU) patients (David Navarro, PhD)
 
Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...
 
Identification of pathological mutations from the single-gene case to exome p...
Identification of pathological mutations from the single-gene case to exome p...Identification of pathological mutations from the single-gene case to exome p...
Identification of pathological mutations from the single-gene case to exome p...
 
C Is Easy
C Is EasyC Is Easy
C Is Easy
 
Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...
 
Encondromatosis
EncondromatosisEncondromatosis
Encondromatosis
 
Lessonplan 100512115922-phpapp02 (2)
Lessonplan 100512115922-phpapp02 (2)Lessonplan 100512115922-phpapp02 (2)
Lessonplan 100512115922-phpapp02 (2)
 
Training presentation
Training presentationTraining presentation
Training presentation
 
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp..."Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
 
Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?
 
The Microcirculation in Sepsis
The Microcirculation in SepsisThe Microcirculation in Sepsis
The Microcirculation in Sepsis
 
Legacy of discord
Legacy of discordLegacy of discord
Legacy of discord
 
kyoto protocol & its impact on india
kyoto protocol & its impact on indiakyoto protocol & its impact on india
kyoto protocol & its impact on india
 

Similar a The impact of SSC 2012 on the planning and evaluation of my hospital's performance The impact of SSC 2012 on the planning and evaluation of my hospital's performance

St. David's Prophylaxis Program
St. David's Prophylaxis ProgramSt. David's Prophylaxis Program
St. David's Prophylaxis ProgramSCBHealth
 
Annual Performance Review (2014) o f light hospital sankore
Annual Performance Review (2014) o f light hospital sankoreAnnual Performance Review (2014) o f light hospital sankore
Annual Performance Review (2014) o f light hospital sankorefoli ernest kwasi
 
Getting started at the national level from demonstration to spread
Getting started at the national level from demonstration to spreadGetting started at the national level from demonstration to spread
Getting started at the national level from demonstration to spreadProqualis
 
Sepsis & Hospice Eligibility: Natural History, Prognosis & Role of Hospice
Sepsis & Hospice Eligibility: Natural History, Prognosis & Role of HospiceSepsis & Hospice Eligibility: Natural History, Prognosis & Role of Hospice
Sepsis & Hospice Eligibility: Natural History, Prognosis & Role of HospiceVITAS Healthcare
 
Fisiol e anat ponv.PONV anatomy and physiology,risk of
Fisiol e anat ponv.PONV anatomy and physiology,risk of Fisiol e anat ponv.PONV anatomy and physiology,risk of
Fisiol e anat ponv.PONV anatomy and physiology,risk of Claudio Melloni
 
Evaluating the Effectiveness of Current Pain Management Strategies
Evaluating the Effectiveness of Current Pain Management StrategiesEvaluating the Effectiveness of Current Pain Management Strategies
Evaluating the Effectiveness of Current Pain Management StrategiesWellbe
 
NSM 2007 Ppt by Jason Musgrave
NSM 2007 Ppt by Jason MusgraveNSM 2007 Ppt by Jason Musgrave
NSM 2007 Ppt by Jason Musgravejclaymusgrave
 
Periodontal Epidemiology.pptx
Periodontal Epidemiology.pptxPeriodontal Epidemiology.pptx
Periodontal Epidemiology.pptxSyedWaliPeeran
 
Osteoporosis 2016 | Hip fracture, the ultimate challenge: Dr Antony Johansen ...
Osteoporosis 2016 | Hip fracture, the ultimate challenge: Dr Antony Johansen ...Osteoporosis 2016 | Hip fracture, the ultimate challenge: Dr Antony Johansen ...
Osteoporosis 2016 | Hip fracture, the ultimate challenge: Dr Antony Johansen ...National Osteoporosis Society
 
How to use quality registry data for quality improvement
How to use quality registry data for quality improvementHow to use quality registry data for quality improvement
How to use quality registry data for quality improvementscanFOAM
 
Scripps lj grand rounds
Scripps lj grand roundsScripps lj grand rounds
Scripps lj grand rounds3GDR
 
How Health IT Can Help Extinguish Physician and Nurse Burnout
How Health IT Can Help Extinguish Physician and Nurse BurnoutHow Health IT Can Help Extinguish Physician and Nurse Burnout
How Health IT Can Help Extinguish Physician and Nurse BurnoutSpok
 
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A sessionNational Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A sessionGraham Atherton
 

Similar a The impact of SSC 2012 on the planning and evaluation of my hospital's performance The impact of SSC 2012 on the planning and evaluation of my hospital's performance (20)

St. David's Prophylaxis Program
St. David's Prophylaxis ProgramSt. David's Prophylaxis Program
St. David's Prophylaxis Program
 
Economics of ni.2019
Economics of ni.2019Economics of ni.2019
Economics of ni.2019
 
Ni escmid-esgni-kayseri 2015
Ni escmid-esgni-kayseri  2015Ni escmid-esgni-kayseri  2015
Ni escmid-esgni-kayseri 2015
 
Economics of Nosocomial Infections (any) Romania-2016
Economics of Nosocomial Infections (any) Romania-2016Economics of Nosocomial Infections (any) Romania-2016
Economics of Nosocomial Infections (any) Romania-2016
 
Annual Performance Review (2014) o f light hospital sankore
Annual Performance Review (2014) o f light hospital sankoreAnnual Performance Review (2014) o f light hospital sankore
Annual Performance Review (2014) o f light hospital sankore
 
Getting started at the national level from demonstration to spread
Getting started at the national level from demonstration to spreadGetting started at the national level from demonstration to spread
Getting started at the national level from demonstration to spread
 
Sepsis & Hospice Eligibility: Natural History, Prognosis & Role of Hospice
Sepsis & Hospice Eligibility: Natural History, Prognosis & Role of HospiceSepsis & Hospice Eligibility: Natural History, Prognosis & Role of Hospice
Sepsis & Hospice Eligibility: Natural History, Prognosis & Role of Hospice
 
Fisiol e anat ponv.PONV anatomy and physiology,risk of
Fisiol e anat ponv.PONV anatomy and physiology,risk of Fisiol e anat ponv.PONV anatomy and physiology,risk of
Fisiol e anat ponv.PONV anatomy and physiology,risk of
 
Detrol
DetrolDetrol
Detrol
 
Give up on VRE?
Give up on VRE?Give up on VRE?
Give up on VRE?
 
UNSW from OCIS to OpenMRS
UNSW from OCIS to OpenMRSUNSW from OCIS to OpenMRS
UNSW from OCIS to OpenMRS
 
Evaluating the Effectiveness of Current Pain Management Strategies
Evaluating the Effectiveness of Current Pain Management StrategiesEvaluating the Effectiveness of Current Pain Management Strategies
Evaluating the Effectiveness of Current Pain Management Strategies
 
EBP-NPWT-G8-Faisal.pptx
EBP-NPWT-G8-Faisal.pptxEBP-NPWT-G8-Faisal.pptx
EBP-NPWT-G8-Faisal.pptx
 
NSM 2007 Ppt by Jason Musgrave
NSM 2007 Ppt by Jason MusgraveNSM 2007 Ppt by Jason Musgrave
NSM 2007 Ppt by Jason Musgrave
 
Periodontal Epidemiology.pptx
Periodontal Epidemiology.pptxPeriodontal Epidemiology.pptx
Periodontal Epidemiology.pptx
 
Osteoporosis 2016 | Hip fracture, the ultimate challenge: Dr Antony Johansen ...
Osteoporosis 2016 | Hip fracture, the ultimate challenge: Dr Antony Johansen ...Osteoporosis 2016 | Hip fracture, the ultimate challenge: Dr Antony Johansen ...
Osteoporosis 2016 | Hip fracture, the ultimate challenge: Dr Antony Johansen ...
 
How to use quality registry data for quality improvement
How to use quality registry data for quality improvementHow to use quality registry data for quality improvement
How to use quality registry data for quality improvement
 
Scripps lj grand rounds
Scripps lj grand roundsScripps lj grand rounds
Scripps lj grand rounds
 
How Health IT Can Help Extinguish Physician and Nurse Burnout
How Health IT Can Help Extinguish Physician and Nurse BurnoutHow Health IT Can Help Extinguish Physician and Nurse Burnout
How Health IT Can Help Extinguish Physician and Nurse Burnout
 
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A sessionNational Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
National Aspergillosis Centre Doctor Livingstone Chishimba holds a Q&A session
 

Más de Vall d'Hebron Institute of Research (VHIR)

"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu..."Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...Vall d'Hebron Institute of Research (VHIR)
 
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ..."Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...Vall d'Hebron Institute of Research (VHIR)
 
Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...Vall d'Hebron Institute of Research (VHIR)
 
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ..."Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...Vall d'Hebron Institute of Research (VHIR)
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To..."Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...Vall d'Hebron Institute of Research (VHIR)
 
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...Vall d'Hebron Institute of Research (VHIR)
 
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...Vall d'Hebron Institute of Research (VHIR)
 
Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Vall d'Hebron Institute of Research (VHIR)
 
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...Vall d'Hebron Institute of Research (VHIR)
 
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ..."The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...Vall d'Hebron Institute of Research (VHIR)
 
Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...Vall d'Hebron Institute of Research (VHIR)
 

Más de Vall d'Hebron Institute of Research (VHIR) (20)

"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu..."Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
 
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ..."Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
 
Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...
 
Data analysis pipelines for NGS applications
Data analysis pipelines for NGS applicationsData analysis pipelines for NGS applications
Data analysis pipelines for NGS applications
 
NGS and the molecular basis of disease: a practical view
NGS and the molecular basis of disease: a practical viewNGS and the molecular basis of disease: a practical view
NGS and the molecular basis of disease: a practical view
 
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemicsProf. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
 
Richard horton, barcelona 2014
Richard horton, barcelona 2014Richard horton, barcelona 2014
Richard horton, barcelona 2014
 
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ..."Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
 
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To..."Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
 
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
 
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ studyDr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
 
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
 
IRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhDIRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhD
 
Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...
 
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
 
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ..."The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
 
Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...
 
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
 
TLR ligand functionalized nanocarriers to enhance immunogenicity of vaccines
TLR ligand functionalized nanocarriers to enhance immunogenicity of vaccinesTLR ligand functionalized nanocarriers to enhance immunogenicity of vaccines
TLR ligand functionalized nanocarriers to enhance immunogenicity of vaccines
 

Último

All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...Arohi Goyal
 
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Availableperfect solution
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...chandars293
 
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426jennyeacort
 
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...Dipal Arora
 
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Dipal Arora
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...aartirawatdelhi
 
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...GENUINE ESCORT AGENCY
 
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...parulsinha
 
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableGENUINE ESCORT AGENCY
 
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In AhmedabadGENUINE ESCORT AGENCY
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...parulsinha
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Ishani Gupta
 
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...khalifaescort01
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...hotbabesbook
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...hotbabesbook
 
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Anamika Rawat
 
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
 
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Anamika Rawat
 

Último (20)

All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
 
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
 
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
 
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
 
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
 
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
 
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
 
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
 
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
 
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
 
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
 
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
 
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
 

The impact of SSC 2012 on the planning and evaluation of my hospital's performance The impact of SSC 2012 on the planning and evaluation of my hospital's performance

  • 1. The impact of SSC 2012 on the panning and evaluation of my hospital's performance Critical Care Department - Hospital Vall d'Hebron Barcelona, June, 10, 2013 Rui Moreno UCINC, Hospital de São José Centro Hospitalar de Lisboa Central, E.P.E.
  • 2. DECLARATION OF POTENTIAL (REAL) CONFLICT OF INTEREST
  • 3. DECLARATION OF POTENTIAL CONFLICT OF INTEREST • I am not an Anaesthesiologist • I am not and Internist • I am not a surgeon • I am not a GP
  • 4. DECLARATION OF POTENTIAL CONFLICT OF INTEREST • I am not an Anaesthesiologist • I am not and Internist • I am not a surgeon • I am not a GP I AM AN INTENSIVIST!
  • 5.
  • 6.
  • 7.
  • 8. THE PATIENT WITH SEPSIS NEED TEAMS, NOT TRIBES!
  • 9.
  • 11. DEFINITIONS Bone et al. Chest. 1992;101:1644; Wheeler and Bernard. N Engl J Med. 1999;340:207. SepsisSIRSInfection/ Trauma Severe Sepsis Sepsis with ≥1 sign of organ failure  Cardiovascular (refractory hypotension)  Renal  Respiratory  Hepatic  Hematologic  CNS  Unexplained metabolic acidosis Shock
  • 12. 800 1,000 1,200 1,400 1,600 1,800 2001 2025 2050 Year 300 400 500 600 SepsisCases(x103) TotalUSPopulation(million) Angus DC, et al. JAMA 2000;284:2762-70. Angus DC, et al. Crit Care Med 2001;29:1303-10. SEVERE SEPSIS IS INCREASING IN INCIDENCE Severe Sepsis Cases US Population
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21. EPIDEMIOLOGY OF SEPSIS IN THE CRITICALLY ILL PATIENT 0% 10% 20% 30% 40% 50% 60% 70% 80% 0-1 2-3 4-6 7-10 11-15 16-21 Days in ICU before the study day Infectionrate N = 6010 1608 1857 1248 1176 742 (EPIC II, 2008)
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27. INFECTION AND OUTCOME 0,0 5,0 10,0 15,0 20,0 25,0 30,0 35,0 40,0 45,0 Mortality,% ICU mortality 13,9 32,2 Hospital mortality 18,7 41,8 No infection Infection (Moreno et al. 2005 - data from the SAPS 3 study)
  • 28.
  • 29. 0% 25% 50% 75% 100% %ofpatients 0 2 4 6 8 10 12 14 16 18 20 22 24 SOFA score Survivors Non-survivors (R. Moreno, 1997) EPIDEMIOLOGY OF SEPSIS IN THE CRITICALLY ILL PATIENT
  • 30. 1 OSF 2 OSF 3 OSF 0 20 40 60 80 100 1 2 3 4 5 6 7 ICUmortality(%) Number of days in MOF ORGAN FAILURE AND MORTALITY IN PATIENTS WITH SEPSIS AND ORGAN FAILURE (data from Moreno et al.)
  • 31.
  • 32.
  • 34. Surviving Sepsis Campaign: Timeline Barcelona Declaration SSC Guidelines 2010 ??? Guidelines And bundles Revision 2005 NEJM editorial 2004 2002 Guidelines Revision Phase III starts: IHI partnership 2008 2012 Results published 15,000 pts 20% RRR 2006 2012--
  • 35. Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock 2004
  • 36. Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock 2008
  • 37. Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock 2012
  • 38.
  • 39. Surviving Sepsis — Practice Guidelines, Marketing Campaigns, and Eli Lilly Peter Q. Eichacker, M.D., Charles Natanson, M.D., and Robert L. Danner, M.D
  • 40. New Policy to deal with Potential Conflicts of Interest
  • 41. GRADE PRO: Guideline development process • Prioritize problems (and define specific question(s) • Perform systematic review • Summarize the evidence in evidence profiles (summary of findings tables) • Judge which outcomes are critical • Judge overall quality of evidence • Judge balance of benefits and downsides • Generate recommendation • Judge strength of recommendation
  • 42. 42
  • 43. 43
  • 44. 4.5 potentials for a mishap per operation
  • 45. NURSING WORK Gets IV bags, Checks orders in binder 13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00 Hangs IV IV push Oral meds, topical cream Checks updates in computer Hangs IV Planning for new shift Checks orders in binderHangs IV Hangs IV Hangs IV Oral meds IV push Oral meds Insulin Hangs IV Pain med Checks updates in computer Topical cream Other RN needs binder Nursing home assessment Narcotic keys Staffing IV pump alarm Fingerstick machine calibration Hand off assessment IV pump alarm Narcotic meds too many to put in cart Narcotic keys Other RN leaves floor Signature for narcotics Move patient to new bed Water for patient New nursing assistant arrives MD asks to tape down IV LPN she is covering Children on floor Patient risk of falling Other RN returns Hang IV for her Pain med request BP machine problems Dinner Patient moved up in bed Water for patient Fingerstick machine IV pump alarm Beds Weigh patient Staffing Other RN dinner Hang IV IV pump alarm Cart Wife of patient Emily S. Patterson PhD
  • 46.
  • 47. Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock Version 2012
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69.
  • 70.
  • 71.
  • 72.
  • 74. van Beeck et al. J Trauma 1997;42:1116 TRAFFIC INJURIES 0 10 20 30 40 50 60 70 80 90 0 10 20 Age in years MillionsofUS$ Male Female
  • 75. van Beeck et al. J Trauma 1997;42:1116 OCCUPATIONAL INJURIES 0 10 20 30 40 50 60 70 80 90 0 1 2 3 4 5 Male Female Age in years MillionsofUS$
  • 76. DOMESTIC INJURIES 0 10 20 30 40 50 60 70 80 90 0 10 20 30 40 50 60 70 80 90 100 Age in years MillionsofUS$ van Beeck et al. J Trauma 1997;42:1116 Male Female
  • 77. 2000 2200 2400 2600 2800 3000 3200 3400 3600 1990 1991 1992 1993 1994 1995 Totalexpenditureinacutecare-MillionEuro Years Denmark TOTAL EXPENDITURE IN HEALTH CARE
  • 79. IF WE WANT TO AVOID A DISASTER OUR FOCUS SHOULD BE ON THE EVALUATION AND OPTIMIZATION OF THE SERVICES WE PROVIDE
  • 80. HOW (UN)RELIABLE IS MEDICINE? • 10-1 means that 1 to 9 times out of 10 the intended actions fail to produce the desired results or are defective. An example is if I have a 80% compliance with giving appropriate DVT prophylaxis there are 2 defects in our process in every 10 patients • 10-2 means that 1 to 9 times out of 100 the intended action or results fail or are defective. An example is if I have 96% compliance with giving appropriate DVT prophylaxis there will be 4 defects in our process in every 100 patients
  • 81. Average Percent High Income Zip Codes Low Income Zip Codes Expected in One Year Diabetic Eye Exams 47,9 53,2 44,9 100,0 Hgb A1c Monitoring 55,9 59,5 50,9 100,0 Mammography Screening 46,7 50,8 39,8 100,0 Colon Cancer Screening 9.0 (45%) 10,3 8,0 20,0 Influenza Vaccine 46,5 50,8 41,5 100,0 Pneunococcal Vaccine 8 (80%) 8,7 7,3 10,0 Pham HH. Delivery of Preventive Services. JAMA 2005; 294:473-481
  • 82. WHAT ARE OUR EXPECTATIONS OF RELIABILITY IN OTHER INDUSTRIES? 1. How many of you would put up with your automobile not starting two out of ten starts? 2. How many of you would fly commercially, if airplanes crashed or abandoned the trip one out of every ten flights? 3. How many of you would frequent a restaurant that served contaminated food three times out of every ten meals?
  • 83.
  • 84. HEALTH CARE RELIABILITIES (Un)Reliability Outcome/Process 10-1 Beta blockers and ASA in Acute MI HgA1c tested at least 3 times every 2 yrs Mammograms, Immunization Lower Vt in ALI Patients. 10-2 Serious adverse events in hospital Deaths in high risk surgery 10-3 Neonatal mortality General surgery deaths 10-4 Deaths in routine anesthesia 10-5 Blood Banking 10-6 ?
  • 85. 10.3 10.5 10.3 9.6 8 7.7 6.9 2 2 2 2 12 21 31 0 5 10 15 20 25 30 35 1996 1997 1998 1999 2000 2001 2002 Median Vt ml/kg % of ARDS Patients Recieving 6 ml/kg Vt ARDS Network Paper Published NEJM May 2000 Death deceased from 40% to 31% p= 0.007 (Am J. Respir & CCM 2004; 169 supp:A256)
  • 86. 10.3 10.5 10.3 9.6 8 7.7 6.9 2 2 2 2 12 21 31 0 5 10 15 20 25 30 35 1996 1997 1998 1999 2000 2001 2002 Median Vt ml/kg % of ARDS Patients Recieving 6 ml/kg Vt ARDS Network Paper Published NEJM May 2000 Death deceased from 40% to 31% p= 0.007 Two Years after publishing the evidence, ‘7’ of 10 patients are NOT receiving best care (Am J. Respir & CCM 2004; 169 supp:A256)
  • 87. TIDAL VOLUME IN THE ICU’S 0 2 4 6 8 10 12 Luhr 1999 Esteban 2000 Esteban 2002 Esteban 2002 ALIVE 2004 SAPS3 mL/kg (João Gouveia et al. Data from the SAPS 3 study)
  • 88. PEEP IN THE ICU’S 0 2 4 6 8 10 12 14 Luhr 1999 Esteban 2000 Esteban 2002 Esteban 2002 ALIVE 2004 SAPS3 cmH2O (João Gouveia et al. Data from the SAPS 3 study)
  • 89.
  • 90.
  • 91. We demand the right to make bad choices.
  • 92. Bad choices yield bad results
  • 93. 4.5 potentials for a mishap per operation
  • 94. NURSING WORK Gets IV bags, Checks orders in binder 13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00 Hangs IV IV push Oral meds, topical cream Checks updates in computer Hangs IV Planning for new shift Checks orders in binderHangs IV Hangs IV Hangs IV Oral meds IV push Oral meds Insulin Hangs IV Pain med Checks updates in computer Topical cream Other RN needs binder Nursing home assessment Narcotic keys Staffing IV pump alarm Fingerstick machine calibration Hand off assessment IV pump alarm Narcotic meds too many to put in cart Narcotic keys Other RN leaves floor Signature for narcotics Move patient to new bed Water for patient New nursing assistant arrives MD asks to tape down IV LPN she is covering Children on floor Patient risk of falling Other RN returns Hang IV for her Pain med request BP machine problems Dinner Patient moved up in bed Water for patient Fingerstick machine IV pump alarm Beds Weigh patient Staffing Other RN dinner Hang IV IV pump alarm Cart Wife of patient Emily S. Patterson PhD
  • 95.
  • 96.
  • 97. Revised SSC Bundles • Based on 2012 SSC guideline Revision • Utilizing analysis of 28,000 pt in the SSC database • New software to be developed • No industry funding utilized in revising guidelines or bundles
  • 98. Revised SSC Bundles • Management bundle dropped • IPP: High compliance at outset of study • No significant change in compliance • Glucose: • Clouded by controversy • Steroids: • OR > 1.0 in SSC analysis • rhAPC: • Significant OR for survival but after the results of PROWESS-SHOCK was withdraw from all markets
  • 99.
  • 100.
  • 101.
  • 102.
  • 103.
  • 104.
  • 105. Sepsis Resuscitation Bundle (To be started immediately and completed within 3 hours) • Serum lactate measured in 3 hours. • Blood cultures obtained prior to antibiotic administration. • Minimize time to administration of broad-spectrum antibiotics with a maximum of 3 hours. • In the event of hypotension and/or lactate > 3mmol/L, deliver a minimum bolus of 30 ml/kg of crystalloid (or colloid equivalent) within 1 hour.
  • 106. Septic Shock Bundle (To be started immediately and completed within 6 hours) • Apply vasopressors for hypotension not responding to initial fluid resuscitation to maintain mean arterial pressure (MAP) > 65 mm Hg. • In the event of persistent arterial hypotension despite volume resuscitation (septic shock) and/or initial lactate > 4 mmol/L (36 mg/dl): • Insert central line • Achieve central venous pressure (CVP) of > 8 mm Hg. • Achieve central venous oxygen saturation (ScvO2) of > 70%.
  • 108.
  • 109.
  • 110. SOAP AND SEPSIS-ANALYZING WHAT COMES OUT IN THE WASH • From the data they obtained, Dr. Vincent and colleagues make a number of observations: • First, sepsis occurs frequently, being reported in almost 40% of patients in the ICU • Second, the frequency of sepsis varies markedly between countries, and countries with higher frequencies of sepsis have higher mortality rates among all patients admitted to the ICU. • Finally, they report that the presence of a positive cumulative fluid balance over the first 72 hrs from the onset of sepsis is, among other variables, independently associated with higher ICU mortality. Warren Lee & Niall Ferguson. Critical Care Medicine2006; 34:552-554)
  • 111. SOAP AND SEPSIS-ANALYZING WHAT COMES OUT IN THE WASH Warren Lee & Niall Ferguson. Critical Care Medicine2006; 34:552-554 )
  • 112. SOAP AND SEPSIS-ANALYZING WHAT COMES OUT IN THE WASH • Data demonstrate that the mortality rate from organ failure was the same for patients with severe sepsis as it was for those without sepsis, suggesting that organ dysfunction, rather than infection per se, is the key. • What could account for these findings? • ...difference in case-mix and ICU admission threshold • ...the higher mortality rate in the ICUs with higher sepsis prevalence might be a marker of overtaxed resources in the ICU or during pre-ICU care • ... it is tempting to speculate that baseline differences in antibiotic use between ICUs may have contributed both to the differences in the reported frequency of sepsis and to the mortality rates observed. Warren Lee & Niall Ferguson. Critical Care Medicine2006; 34:552-554 )
  • 113. (Crit Care Med 2006; 34:211–218)
  • 114. FINDING OUT WHAT WE DO IN THE ICU Mitchell M. Levy, MD, FCCM • This task force represents a change in focus, not only for SCCM in particular but for the field of critical care in general. • ...for a long time, SCCM, along with other critical care societies, focused on the model of critical care delivery. • Regardless of the model of critical care delivery, the most important aspect of critical care is the quality of care patients receive in a given ICU. • For many years, the assessment of this quality was based on measuring and reporting outcomes of care. • Now, finally, there is a growing understanding that paying attention to the details or process of care is the truly essential aspect of quality measurement in the ICU. (Crit Care Med 2006; 34:227–228)
  • 115. FINDING OUT WHAT WE DO IN THE ICU Mitchell M. Levy, MD, FCCM • Curtis et al., at the direction of SCCM, have provided clinicians in critical care units with a blue-print or mirror for self-examination. The next step is for critical care clinicians to look into that mirror and decide whether or not we like what we see. (Crit Care Med 2006; 34:227–228)
  • 116.
  • 117. NEGOVSKY IBSEN SAFAR WE HAVE STRONG SCIENTIFIC FOUNDATIONS TO OUR SPECIALITY
  • 118. FROM REANIMATION TO INTENSIVE CARE MEDICINE REANIMATION INTENSIVE CARE INTENSIVE CARE MEDICINE
  • 119. 20 years ago Dr Bill Knaus acknowledged: • It ’ s the human resources of the ICU TEAM, their organization and distribution, and how we apply technology consistently, NOT the genius of individuals or the treatment “ magic bullet ” that leads to EFFICIENT and EFFECTIVE ICU. Knaus et al Annals Int Med 1986: 104.410
  • 120. DISEASES THAT MADE THE ICU Polio: Mortality 60% to 20% ??? (but just in 2 or 3 countries) Tetanus: Mortality approaches Zero Guillian-Barré syndrome: Mortality approaches Zero Acute organophosphate poisoning: almost disapeared Most of the mortality relates to co-morbidity and complications of ICU treatment.
  • 121.
  • 122. DEVELOPMENT AS A CHALENGE • Education and training of new professionals. • Training in Intensive care of other professionals. • Better much between resources and workload. • The flux of patients within the hospital: admission and discharge policies, readmissions. • Patient safety: prevention of adverse events. • Organisative aspects: leadership, communication, team- work.
  • 123. Current and projected workforce requirements for care of the critically ill. Angus D et al. JAMA 2000 : 284; 2762-70
  • 124. RETIRE FROM ICU CARE AT 77 YEARS: (Angus et. Al, JAMA 2002)
  • 125. 0 50 100 150 200 250 300 350 400 2001 2006 2011 2016 2021 2026 2031 Year At 2006 rates Modelling trend ICNARCIntensiveCareNationalAudit&ResearchCentre 160% increase in demand over 10 years. Projected ICU Bed Day Requirements Rowan K et al
  • 126. INTENSIVE CARE IS NOT ABOUT MACHINES IT IS ABOUT PEOPLE IT IS ABOUT ORGANIZATION
  • 127. 12
  • 128.
  • 129. 12
  • 130. NUMBER OF INTENSIVE CARE BEDS PER 100.000 INHABITANTS Portugal USA França UK Canadá Bélgica Alemanha HolandaEspanha 0 5 10 15 20 25 30 0 2 4 6 8 10 13 nºdecamasdeMedicinaIntensiva por100.000habitantes Países (Data from Wunsch et all, 2008)
  • 131. NUMBER OF INTENSIVE CARE BEDS PER 100.000 INHABITANTS Portugal USA França UK Canadá Suécia Holanda Espanha Croácia Bélgica Alemanha 0 5 10 15 20 25 0 2 4 6 8 10 12 14 Trinidá e Tobago 13 Países nºdecamasdeMedicinaIntensiva por100.000habitantes (Data from Adhikari et al., 2010)
  • 132. 13
  • 133. • ≈2 millions Total n° Acute Care Beds • ≈ 60.000 Total N° IC Beds • ≈3% IC Beds/AC Beds % Acute and intensive care beds in Europe…….
  • 134. (Andrew Rhodes & Rui Moreno, 2012, ICM)
  • 135. Acute care beds Acute care hospital beds / 100,000 population. Total number of ICU and IMCU care beds Total Adult ICU and IMCU beds / 100,000 population Adult ICU beds as % of all acute care beds %>65 Andorra 188 224 6 7.1 3.2 13 Austria 48446 635 1833 21.8 3.4 18.2 Belgium 50156 456 1900 17.3 3.8 18 Bulgaria 57460 766 2154 28.7 3.7 18.2 Croatia 15629 353 650 14.7 4.2 16.9 Cyprus 2813 350 92 11.4 3.3 10.4 Czech Republic 91068 865 1227 11.6 1.3 16.3 Denmark 17124 308 372 6.7 2.2 17.1 Estonia 5096 380 262 19.5 5.1 17.7 Finland 12442 231 329 6.1 2.6 17.8 France 232821 358 10540 16.2 4.5 16.8 Germany 469791 575 23,890 29.2 5.1 20.6 Greece 44411 392 680 6 1.5 19.6 Hungary 41574 416 1374 13.8 3.3 16.9 Iceland 1169 367 29 9.1 2.5 12.7 Ireland 12202 272 289 6.5 2.4 11.6 Italy 201932 333 7,550 12.5 3.7 20.3 Latvia 11833 531 217 9.7 1.8 16.9 Lithuania 17061 526 502 15.5 2.9 16.5 Luxemberg 2511 491 127 24.8 5.1 14.9 Netherlands 56085 337 1065 6.4 1.9 15.6 Norway 13639 277 395 8 2.9 16 Poland 156662 410 2635 6.9 1.7 13.7 Portugal 31722 298 451 4.2 1.4 18 Romania 108611 507 4574 21.4 4.2 14.8 Slovakia 32560 599 500 9.2 1.5 12.8 Slovenia 7656 373 131 6.4 1.7 16.8 Spain 124194 269 4479 9.7 3.6 17.1 Sweden 26131 278 550 5.8 2.1 19.7 Switzerland 28096 357 866 11 3.1 17 United Kingdom 147809 237 4114 6.6 2.8 16.5
  • 136. Total size of Population Gross Domestic Product (GDP) ($millions) Gross Domestic Product (GDP) per inhabitant ($) Total expenditure on health as a % of GDP Andorra 84082 2893 34,407 7.7 Austria 8404252 377,382 44,904 8.6 Belgium 11007020 467,779 42,498 8.2 Bulgaria 7504868 47,702 6,356 4.4 Croatia 4425747 60,834 13,745 7.8 Cyprus 804435 23,174 28,808 6.0 Czech Republic 10532770 192,030 18,232 6.9 Denmark 5560628 309,866 55,725 9.8 Estonia 1340194 19,253 14,366 5.3 Finland 5375276 239,177 44,496 6.8 France 65075310 2,562,742 39,381 9.2 Germany 81748892 3,286,451 40,202 8.9 Greece 11329618 305,415 26,957 5.8 Hungary 9986000 130,421 13,060 5.2 Iceland 318452 12,594 39,548 7.9 Ireland 4480176 206,985 46,200 7.2 Italy 60626508 2,055,114 33,898 7.4 Latvia 2229641 24,013 10,770 8.1 Lithuania 3244601 36,370 11,209 7.8 Luxemberg 511840 54,950 107,358 4.1 Netherlands 16654979 780,668 46,873 5.5 Norway 4920305 412,990 83,936 8.1 Poland 38200037 469,401 12,288 5.3 Portugal 10636979 229,154 21,543 5.7 Romania 21413815 161,629 7,548 5.4 Slovakia 5435273 87,450 16,089 6.0 Slovenia 2050189 47,733 23,282 6.8 Spain 46152926 1,409,946 30,549 7.0 Sweden 9415570 458,725 48,720 8.2 Switzerland 7866500 527920 67,110 6.8 United Kingdom 62435709 2,250,209 36,040 8.2
  • 137. (Andrew Rhodes & Rui Moreno, 2012, ICM)
  • 138. (Andrew Rhodes & Rui Moreno, 2012, ICM)
  • 139. (Andrew Rhodes & Rui Moreno, 2012, ICM
  • 140. (Andrew Rhodes & Rui Moreno, 2012, ICM)
  • 141. (Andrew Rhodes & Rui Moreno, 2012, ICM
  • 144. • Intensivist model (closed) reduced mortality. (OR: 0.71 95%CI 0.62-0.82) • Intensivist model (closed) reduced length of stay Pronovost et al. JAMA; 2002-2151 Physician staffing patterns and clinical outcomes in critically ill patients.
  • 145. Most Positive Factors Most Negative factors Intellectual stimulation Lack of leisure time Treating acutely ill patients Stress among faculty Application of complex physiology Treating chronically ill patients Procedure orientated Inconsistent with my personality Dealing with end-of-life issues Dealing with complex ethical issues. Attitudes and Perceptions of Internal Medicine Residents Regarding Pulmonary and Critical Care Subspecialty Training. Lorin S et al. Chest 2005 : 127; 630-6.
  • 146. “Beauty comes first. Victory is secondary. What matters is joy.” Sócrates Brasileiro Sampaio de Souza Vieira de Oliveira
  • 147. 14
  • 149.
  • 150.
  • 151.
  • 152.
  • 153.
  • 154. “The physician must be able to tell the antecedents, know the present, and foretell the future- must mediate these things, and have two special objects in view with regard to disease, namely, to do good or to do no harm. The art consists in three things- the disease, the patient, and the physician. The physician is the servant of the art, and the patient must combat the disease along with the physician.” Hippocrates, in Epidemics, Book 1, section 11